secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARGO Therapeutics, Inc. (—)
CIK:        0001966494
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001193125-24-154262
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CARGO Therapeutics appoints Jane Pritchett Henderson to board, expands to 8 directors
--------------------------------------------------------------------------------

- Board expanded from 7 to 8; Henderson appointed as Class III director through 2026 annual meeting.
- Henderson currently CFO of Apogee Therapeutics; will serve on Audit and Compensation Committees.
- Receives standard non-employee director compensation: $40k annual retainer plus option grants.
- At June 4 annual meeting, stockholders elected Viswanadhan and Huber as Class I directors.
- Ratified Deloitte & Touche as independent auditor for FY2024 with 26,079,444 votes for, 1,081 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1966494/000119312524154262/0001193125-24-154262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1966494/000119312524154262/d844498d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-154262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer